Skip to main content

Sophie Porter

By Sophie Porter | 03:33 pm | February 09, 2021
Weekly data will soon be released alongside NHS Test and Trace data to create a better picture of how the UK is tracking COVID-19 and breaking the chain of transmission.
By Sophie Porter | 02:19 am | February 08, 2021
Already the most used digital triage platform in the NHS, the boost will enable the service to expand into urgent and specialist care.
By Sophie Porter | 04:21 am | February 04, 2021
The B2B platform, billed as the “plug and play” option for insurance companies, will use the funding to expand operations in new markets and add languages.
By Sophie Porter | 04:33 am | January 13, 2021
Using Spry’s technology, Itamar plans to develop a wearable RPM device for end-to-end digital care for OSA sufferers.
By Sophie Porter | 03:09 am | January 06, 2021
The move has been lauded by the GMDN Agency as a “valuable resource for the UK healthcare sector”.
By Sophie Porter | 01:11 pm | November 03, 2020
  The accelerator project has created over 200 jobs in life sciences and medtech companies in the last five years, creating opportunity in an otherwise very expensive field
By Sophie Porter | 07:48 am | November 03, 2020
The new report from Research2Guidance (R2G) highlights the current state of the most developed digital health sector, locating service expansion into comorbidities as a key trend.
By Sophie Porter | 03:47 am | October 28, 2020
The funding was led by ETF and an investor consortium from across AI, science and analytics.
By Sophie Porter | 03:51 am | October 27, 2020
EIS fund manager Parkwalk led the funding round alongside existing investors Jonathon Milner, Cambridge Enterprise and Martlet.
By Sophie Porter | 04:00 am | October 07, 2020
British integrated optics solutions company Rockley Photonics have raised $50 million in growth funding led by Credit Suisse-backed SIG-i Capital and the venture capital arm of Applied Materials Inc., Applied Ventures, LLC. The optics solutions provider also received backing from deep-tech VCs, institutional funds, strategic investors and existing shareholders.